Status:
RECRUITING
Impact of Sleep-Disordered Breathing Management in Systemic Hypertension Control: METASLEEP Project
Lead Sponsor:
Sociedad Española de Neumología y Cirugía Torácica
Collaborating Sponsors:
Instituto de Salud Carlos III
Conditions:
Hypertension
Obstructive Sleep Apnea
Eligibility:
All Genders
18+ years
Brief Summary
Hypertension is a frequent condition affecting 11M Spanish citizens and is the leading modifiable contributor to cardiovascular disease and death. Our society has already identified balanced diet, phy...
Detailed Description
This project aims to implement a new hypertension management system, which will include the monitoring and treatment of respiratory disorders during sleep. This new precision medicine-based management...
Eligibility Criteria
Inclusion
- Patients with arterial hypertension who visit their primary care physician in one of the participating primary care centers.
- Signature of the informed consent.
Exclusion
- Psycho-physical inability to complete questionnaires.
- Patients with very limiting chronic disease.
- Previous diagnosis of OSA or any other sleeping disorder
- Active treatment with CPAP.
- Fixed night shift worker.
Key Trial Info
Start Date :
April 16 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
1523 Patients enrolled
Trial Details
Trial ID
NCT05986487
Start Date
April 16 2024
End Date
December 1 2025
Last Update
December 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitari Arnau de Vilanova
Lleida, Spain, 25198